Schedule 13D ownership disclosure

TRAWS PHARMA INC

Security class unavailable · CUSIP: 68232V801

Event date: 2024-04-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,645,100
Percent of class
6.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-24-001418
Form type
SC 13D
Filer
Traws Pharma, Inc.
CIK
CIK 1130598
Filed
Apr 08, 2024
Reporting period
Apr 01, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub